Cargando…

Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression

BACKGROUND: Hepatocellular carcinoma (HCC) remains difficult to cure due to lack of effective treatment and the molecular mechanisms are complex and not completely understood. In this study, We investigated the role of CDK16 in tumor progression of HCC. METHODS: We interrogated the expression level...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yitao, Qin, Xian, Guo, Tao, Liu, Pengpeng, Wu, Ping, Liu, Zhisu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514535/ https://www.ncbi.nlm.nih.gov/pubmed/28716136 http://dx.doi.org/10.1186/s13046-017-0569-2

Ejemplares similares

Retraction Note: Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression
por: Wang, Yitao, et al.
Publicado: (2019)

Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma
por: Ma, Zhili, et al.
Publicado: (2019)

Evaluation of Targeted Agents for Advanced and Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis
por: Guo, Tao, et al.
Publicado: (2019)

A novel microRNA miR-MTCO3P38 inhibits malignant progression via STAT3/PTTG1/MYC in hepatocellular carcinoma
por: Guo, Deliang, et al.
Publicado: (2021)

FCN3 inhibits the progression of hepatocellular carcinoma by suppressing SBDS-mediated blockade of the p53 pathway
por: Ma, Dong, et al.
Publicado: (2023)

YY1-Targeted RBM15B Promotes Hepatocellular Carcinoma Cell Proliferation and Sorafenib Resistance by Promoting TRAM2 Expression in an m6A-Dependent Manner
por: Tan, Chunzhong, et al.
Publicado: (2022)

Identification of 13 Key Genes Correlated With Progression and Prognosis in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis
por: Gu, Yang, et al.
Publicado: (2020)

LINC00265 Promotes Metastasis and Progression of Hepatocellular Carcinoma by Interacting with E2F1 at The Promoter of CDK2
por: Ge, Beihai, et al.
Publicado: (2022)

Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling
por: Liao, Yan, et al.
Publicado: (2017)

Genome stability-related lncRNA ZFPM2-AS1 promotes tumor progression via miR-3065-5p/XRCC4 in hepatocellular carcinoma
por: Liu, Jie, et al.
Publicado: (2022)

The C/D box small nucleolar RNA SNORD52 regulated by Upf1 facilitates Hepatocarcinogenesis by stabilizing CDK1
por: Li, Cuicui, et al.
Publicado: (2020)

Neurotrophin3 promotes hepatocellular carcinoma apoptosis through the JNK and P38 MAPK pathways
por: Yang, Zhangshuo, et al.
Publicado: (2022)

circRNA 001306 enhances hepatocellular carcinoma growth by up‐regulating CDK16 expression via sponging miR‐584‐5p
por: Liu, Qian, et al.
Publicado: (2020)

Identifying miRNA-mRNA Pairs and Novel miRNAs from Hepatocelluar Carcinoma miRNomes and TCGA Database
por: Wu, Ping, et al.
Publicado: (2019)

hSulf-1 inhibits cell proliferation and migration and promotes apoptosis by suppressing stat3 signaling in hepatocellular carcinoma
por: LIU, LING, et al.
Publicado: (2014)

Human Endogenous Retroviruses-K (HML-2) Expression Is Correlated with Prognosis and Progress of Hepatocellular Carcinoma
por: Ma, Weijie, et al.
Publicado: (2016)

Overexpressed DEPDC1B contributes to the progression of hepatocellular carcinoma by CDK1
por: Dang, Xiao-Wei, et al.
Publicado: (2021)

Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis
por: Lu, Ye-Bin, et al.
Publicado: (2017)

TDO Promotes Hepatocellular Carcinoma Progression
por: Li, Shanbao, et al.
Publicado: (2020)

MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma
por: Shen, Zhenghai, et al.
Publicado: (2017)

Long noncoding RNA HOXC-AS3 interacts with CDK2 to promote proliferation in hepatocellular carcinoma
por: Su, Chen, et al.
Publicado: (2022)

CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1
por: Li, Xiao, et al.
Publicado: (2022)

CDK9 is up-regulated and associated with prognosis in patients with papillary thyroid carcinoma
por: Guo, Tao, et al.
Publicado: (2022)

Deoxyribonuclease 1-like 3 Inhibits Hepatocellular Carcinoma Progression by Inducing Apoptosis and Reprogramming Glucose Metabolism
por: Xiao, Yusha, et al.
Publicado: (2022)

SKA3 Promotes tumor growth by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma
por: Hou, Yuchen, et al.
Publicado: (2019)

miR-96-5p Suppresses the Progression of Nasopharyngeal Carcinoma by Targeting CDK1
por: Luo, Xiaoqin, et al.
Publicado: (2020)

The clinical effects of antibiotic prophylaxis for hysteroscopic procedures: A meta-analysis
por: Guo, Tao, et al.
Publicado: (2019)

Evaluation of different antibiotic prophylaxis strategies for hepatectomy: A network meta-analysis
por: Guo, Tao, et al.
Publicado: (2019)

Identifying the superior antibiotic prophylaxis strategy for breast surgery: A network meta-analysis
por: Guo, Tao, et al.
Publicado: (2019)

PRMT5 competitively binds to CDK4 to promote G1-S transition upon glucose induction in hepatocellular carcinoma
por: Yang, Hao, et al.
Publicado: (2016)

KMO in the promotion of tumor development and progression in hepatocellular carcinoma
por: Xu, Jun, et al.
Publicado: (2023)

Long noncoding RNA HULC promotes hepatocellular carcinoma progression
por: Zhang, Hongwei, et al.
Publicado: (2019)

Decreased expression of long non-coding RNA GAS5 indicates a poor prognosis and promotes cell proliferation and invasion in hepatocellular carcinoma by regulating vimentin
por: CHANG, LEI, et al.
Publicado: (2016)

Karyopherin subunit-α 2 expression accelerates cell cycle progression by upregulating CCNB2 and CDK1 in hepatocellular carcinoma
por: Gao, Chun-Lin, et al.
Publicado: (2018)

CDK16 Phosphorylates and Degrades p53 to Promote Radioresistance and Predicts Prognosis in Lung Cancer
por: Xie, Jie, et al.
Publicado: (2018)

Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma
por: Huang, Shanzhou, et al.
Publicado: (2020)

Progress of MRI Radiomics in Hepatocellular Carcinoma
por: Gong, Xue-Qin, et al.
Publicado: (2021)

Loss of ARID1A Promotes Hepatocellular Carcinoma Progression via Up-regulation of MYC Transcription
por: Xiao, Yao, et al.
Publicado: (2021)

DNASE1L3 arrests tumor angiogenesis by impairing the senescence-associated secretory phenotype in response to stress
por: Guo, Deliang, et al.
Publicado: (2021)

CircCDK14 Promotes Tumor Progression and Resists Ferroptosis in Glioma by Regulating PDGFRA
por: Chen, Simin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ft6rjgqfsddgg5vhbs583i196l